Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia
Our study enriches the current AML risk stratification and provides guidance for precision medicine in AML.
Authors
- Hebing Zhou (ORCID: https://orcid.org/0000-0002-7486-7585)
- Yue Zhang (ORCID: https://orcid.org/0000-0003-4597-9964)
- Tingting Chen (ORCID: https://orcid.org/0000-0002-3918-5132)
- Danyang Zhang (ORCID: https://orcid.org/0000-0002-7720-4058)
Institutions
- Beijing Luhe Hospital Affiliated to Capital Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-08
- DOI
- https://doi.org/10.3389/fimmu.2024.1451486
- Citations
- 4
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.82